Pyott David E I

Allergan Inc.

Chairman of the Board and CEO, Director

Avg. Two Year Performance

92% Avg. Purchase Return 39% Compound

(61%) Avg. Sale Return (27%) Compound

Holdings: 0 shares

Last Three Months: 25-Aug-24 -- 24-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions